Related Experiment Video
Updated: Jun 16, 2026
07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Thalamic volumes in patients with bipolar disorder
Katrin Radenbach1, V Flaig, T Schneider-Axmann
1Department of Psychiatry and Psychotherapy, Georg-August-University Goettingen, von-Siebold-Str. 5, 37075, Goettingen, Germany. kradenb@gwdg.de
European Archives of Psychiatry and Clinical Neuroscience
|February 4, 2010
Summary
Bipolar disorder patients not on lithium showed a smaller right thalamus volume compared to controls. This suggests the thalamus
Area of Science:
- Neuroscience
- Psychiatry
- Neuroimaging
Background:
- Functional neuronal networks are hypothesized to underlie mood regulation and bipolar disorder.
- The thalamus is a key structure implicated in mood modulation and the etiology of bipolar disorder.
- Previous structural brain imaging studies on bipolar patients' thalamus volume have yielded inconsistent results.
Purpose of the Study:
- To compare thalamus volume in euthymic bipolar patients and healthy controls using structural MRI.
- To investigate the relationship between thalamus volume and medication, particularly lithium, in bipolar disorder.
Main Methods:
- Structural magnetic resonance imaging (MRI) was used to assess thalamus volume.
- Forty-one euthymic bipolar patients were compared to 41 matched healthy controls.
- Analysis of variance was employed, with concomitant medication considered as a covariate.
Main Results:
- A significantly smaller relative volume of the right thalamus was observed in bipolar patients not treated with lithium compared to healthy controls.
- No significant differences in thalamus volume were found between all euthymic bipolar patients (regardless of medication) and healthy controls.
- The study was cross-sectional, lacking longitudinal data and detailed pharmacological histories.
Conclusions:
- The findings suggest a potential role for the right thalamus in the pathogenesis of bipolar I disorder, particularly in patients not receiving lithium.
- Further longitudinal studies are needed to investigate the impact of medication, especially lithium, on thalamus volume in bipolar disorder.
- The thalamus' involvement in mood regulation warrants continued investigation within the context of bipolar disorder.
Related Concept Videos
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...